忍者ブログ

ニュースリリースのリリースコンテナ第二倉庫

ニュースサイトなど宛てに広く配信された、ニュースリリース(プレスリリース)、 開示情報、IPO企業情報の備忘録。 大手サイトが順次削除するリリースバックナンバーも、蓄積・無料公開していきます。 ※リリース文中の固有名詞は、発表社等の商標、登録商標です。 ※リリース文はニュースサイト等マスコミ向けに広く公開されたものですが、著作権は発表社に帰属しています。

2025'01.23.Thu
×

[PR]上記の広告は3ヶ月以上新規記事投稿のないブログに表示されています。新しい記事を書く事で広告が消えます。

2007'10.31.Wed
Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' -- A Quarterly Review of Scientific Literature on Drugs and Therapies From April -- June 2007
October 16, 2007


Novartis Takes Top Spot, Previously Held by GlaxoSmithKline
Since June 2006


    PHILADELPHIA and LONDON, Oct. 16 /Xinhua-PRNewswire/ --
Thomson Scientific, part of The Thomson Corporation (NYSE:
TOC; TSX: TOC) and leading provider of information
solutions to the worldwide research and business
communities, today announced the availability of its most
recent quarterly review of scientific literature on drugs
and therapies. "Who is Making the Biggest
Splash?" was created to provide an objective
assessment of how this tremendous volume of research is
being received within the clinical community and to give
expert measured insight into organizations that helped to
shape professional opinions. In this quarterly review,
Thomson Scientific has assessed the quantity and quality of
the materials published by pharmaceutical companies,
research institutions and other non-commercial from April -
June 2007 to identify which organization has made the
biggest splash.

    Novartis gained pole position in this quarter's
analysis, knocking GlaxoSmithKline out of the top spot for
the first time since June 2006. Researchers affiliated with
the firm issued 82 articles, abstracts or scientific posters
between April and June 2007, more than the 73 identified in
the previous quarter. The company maintained its solid
Thomson Source Score of 76. Three of the other
organizations at the top of the list (AstraZeneca,
GlaxoSmithKline, and Eli Lilly) this quarter also ranked in
the top five last quarter. 

    "The international pharmaceutical industry is
among the most active sponsors of scientific research, so
it is understandable that our findings confirm that
scientific articles affiliated with, or sponsored by,
pharmaceutical companies provide a robust level of
information for readers of scientific journals," said
Larry Liberti, VP, General Manager, Thomson Pharmaceutical
Services. "Our one-of-a-kind report finds that many
pharmaceutical companies have good grounds for saying what
they say - and judging by their source score, say it
well." 

    Other key findings include:
    -- GlaxoSmithKline drops to fourth, with 18 less
sources than Novartis.
    -- Big Pharma features prominently, representing all
entries except for 
       the two US National Institutes of Health. 
    -- There was a notable change from previous quarters
where at least one 
       discovery or biotechnology company was represented
in the top ten.
    -- No companies in the top 15 exceed a Thomson Source
Score of 80%. 
    -- The top six entries are among the world's leading
pharmaceutical 
       companies.

    Findings are based on information compiled from Thomson
Pharma(R) and the Thomson Message Mapping System(SM), which
provides data to the pharmaceutical industry in real-time,
evaluating specific drugs and therapies against competitors
as new studies are being published, helping pharmaceutical
companies to measure the overall impact of published
scientific information. 

    For a full copy of the report with analysis, please
visit:
http://www.thomsonpharma.com/media/pdfs/tpqr/making-a-splash-apr2007.pdf

    About The Thomson Corporation

    The Thomson Corporation ( http://www.thomson.com ) is a
global leader in providing essential electronic workflow
solutions to business and professional customers. With
operational headquarters in Stamford, Conn., Thomson
provides value-added information, software tools and
applications to professionals in the fields of law, tax,
accounting, financial services, scientific research and
healthcare. The Corporation's common shares are listed on
the New York and Toronto stock exchanges (NYSE: TOC; TSX:
TOC). 

    Thomson Scientific is a business of The Thomson
Corporation. Its information solutions assist professionals
at every stage of research and development-from discovery to
analysis to product development and distribution. Thomson
Scientific information solutions can be found at
scientific.thomson.com.


    For more information, please contact:

     Eoin Bedford
     Thomson Scientific
     Tel:   +44-207-433-4691
     Email: eoin.bedford@thomson.com

PR
Post your Comment
Name:
Title:
Mail:
URL:
Color:
Comment:
pass: emoji:Vodafone絵文字 i-mode絵文字 Ezweb絵文字
trackback
この記事のトラックバックURL:
[15451] [15450] [15449] [15448] [15447] [15446] [15445] [15444] [15443] [15442] [15441
«  BackHOME : Next »
広告
ブログ内検索
カウンター

忍者ブログ[PR]